Global Immunohistochemistry Market Assessment, By Product [Reagents, Equipment, Antibodies, Kits], By Applications [Diagnostic, Research, Forensic], By End-users [Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
Global immunohistochemistry market size is expanding due to surge in diverse applications such as research, personalized medications, precision diagnostics and treatments.
Home>Industry Reports>Global Immunohistochemistry Market Assessment, Opportunities and Forecast, 2017-2031F
Global immunohistochemistry market size was valued at USD 3.01 billion in 2023, which is expected to reach USD 4.99 billion in 2031, with a CAGR of 6.51% for the forecast period between 2024 and 2031F. The growth of the global immunohistochemistry market is driven by rising cancer rates, technological progress, expanding research endeavors, the surge in personalized medicine demand, increased healthcare spending, and the necessity for precise diagnostic instruments.
The growth of the global immunohistochemistry market hinges on a multitude of pivotal factors driving its upward momentum. Initially, the surging prevalence of global cancer cases serves as a primary catalyst. Immunohistochemistry's pivotal role in identifying specific cancer markers in tissues has become indispensable in diagnosing, prognosing, and selecting treatments, thereby significantly boosting its demand in the global immunohistochemistry market, particularly within oncology. Simultaneously, the landscape of technological advancements has profoundly transformed immunohistochemistry methodologies, elevating their precision, sensitivity, and ability to handle multiple markers concurrently. The progression has widened the array of applications, fostering its adoption across diverse research and clinical fields.
Furthermore, the burgeoning interest in personalized medicine and the substantial investments in this realm have fueled the need for accurate, tailored diagnostic approaches. Immunohistochemistry's capacity to provide personalized insights into disease pathology seamlessly aligns with the paradigm shift toward individualized patient care. Moreover, the substantial rise in healthcare expenditure, notably in diagnostic technologies, has provided robust support for expanding the global immunohistochemistry market. The imperative demand for dependable diagnostic tools across varied medical domains further solidifies the sustained growth of global immunohistochemistry market.
Rising Cancer Rates
The expansion of the global immunohistochemistry market stems from the worldwide increase in cancer rates. With the surge in cancer cases, there's an amplified necessity for precise diagnostic tools. Immunohistochemistry stands out for its capability to pinpoint proteins and biomarkers within tissues, which is critical in diagnosing, prognosing, and selecting treatments for cancer. Technology allows for the accurate identification and characterization of cancerous cells, assisting medical professionals in comprehending tumor behavior and devising customized treatment plans. The growing demand for efficient, personalized cancer therapies has led to a wider adoption of immunohistochemistry techniques. Its capacity to offer intricate insights into various tumor types and molecular compositions has solidified its indispensable status in oncology. Consequently, the ongoing escalation of cancer incidence is a pivotal driver fueling the continual growth and expansion of the global immunohistochemistry market.
Technological Advancements
Technological progress is the primary driver behind expanding the global immunohistochemistry market. Advancements in this arena have transformed methodologies, boosting precision, sensitivity, and the ability to handle multiple markers simultaneously. These developments expand the range of applications for immunohistochemistry, fostering its use across various research and clinical fields. Evolution allows for the precise detection and characterization of specific proteins and biomarkers in tissues, crucial for precise diagnosis, prognosis, and treatment decisions. Consequently, the ongoing innovation and enhancement of technology significantly contribute to the market's growth by enhancing effectiveness, dependability, and the breadth of insights provided by immunohistochemistry methods.
Launched in September 2023, SignalStar Multiplex IHC technology is a game-changing new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays. Cell Signalling Technology (CST) is a life science discovery technology company and a leading provider of antibodies, kits, and services. Using flexible, thoroughly validated antibody panels, the SignalStar method concurrently identifies up to eight targets in formalin-fixed, paraffin-embedded (FFPE) tissues, enabling the investigation of cellular presence, location, function, and biomarker coexpression patterns.
IHC for Cancer Treatment
The increasing need for immunohistochemistry in treating cancer is a crucial driver for the global immunohistochemistry market. Its essential function involves accurately diagnosing cancer, predicting outcomes, and guiding treatment choices. Immunohistochemistry assists in customizing treatment plans by identifying precise proteins and biomarkers in tissues. As personalized medicine gains traction, the technology's role in providing intricate details about tumor features becomes more vital. The growing dependence on immunohistochemistry in cancer management fuels its acceptance, propelling market expansion as healthcare systems globally emphasize precise and individualized methods to address the complexities associated with cancer.
Leica Biosystems announced on April 20, 2023, that the BOND MMR Antibody Panel has received US Food and Drug Administration (FDA) 510(k) clearance. The clearance gives customers an excellent option for IHC Mismatch Repair (MMR) when screening patients with colorectal cancer for the presence of probable Lynch syndrome. The Leica Biosystems BOND MMR panel on the BOND-III allows pathologists to analyze the state of mismatch repair proteins quickly and accurately in about 2.5 hours. Clinicians can feel more confident in their MMR results with the panel.
Dominance of Antibody Products
The dominance of antibody products in the global immunohistochemistry market is a crucial catalyst. Antibodies are pivotal in these assays, selectively binding to target proteins and facilitating their detection in tissue samples. The market's expansion is driven by the growing utilization of antibodies in research and diagnostic contexts. Their precision and sensitivity render them essential in pinpointing disease markers, crucial for precise diagnoses and treatment planning. With the increasing demand for accurate detection techniques, the indispensable nature of antibody products consistently propels the growth of the global immunohistochemistry market.
The global antibody manufacturing company GeneTex stated in June 2023 that it will use its platform for producing recombinant monoclonal antibodies to provide best-in-class biomedical research reagents. The specificity of these novel antibodies is established through rigorous internal validation testing based on knockdown/knockout approaches supplemented by additional strategies. Using the procedure, GeneTex created and validated a new recombinant rabbit monoclonal antibody for immunohistochemistry (IHC) called programmed death-ligand 1 (PD-L1).
Future Market Scenario
The prospects for the global immunohistochemistry market are positive and positioned for substantial expansion. Several factors underpin the positive forecast. Ongoing technological advancements consistently improve the precision, sensitivity, and multiplexing capabilities of immunohistochemistry methods, broadening their use in various research and clinical realms. Also, the increasing prevalence of global diseases, particularly cancer, intensifies the need for accurate diagnostic tools, emphasizing the vital role of immunohistochemistry in identifying specific disease markers in tissues.
Furthermore, the growing emphasis on personalized medicine encourages the adoption of immunohistochemistry for its ability to offer intricate insights into personalized disease attributes, aligning well with the trend toward individualized patient care. Continued governmental support, augmented investments in healthcare infrastructure, and the indispensable nature of antibody products in the sector collectively signal a promising future for the global immunohistochemistry market, ensuring sustained growth and innovative strides in diagnostics and tailored healthcare solutions.
Report Scope
“Global Immunohistochemistry Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global immunohistochemistry market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024-2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031F |
|
Projected Growth Rate |
CAGR of 6.51% between 2024-2031F |
|
Revenue Forecast in 2031 |
USD 4.99 billion |
|
Units |
Revenue in USD billion |
|
Segments Covered |
Product, Applications, End-users |
|
Regions Covered |
North America, South America, Europe, Asia-Pacific, Middle East and Africa |
|
Agilent Technologies, Inc., Danaher Corporation, PHC Holdings Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., Abcam plc, PerkinElmer Inc., Takara Bio Inc. |
|
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global immunohistochemistry market has been segmented into the following categories:
· By Product
o Reagents
§ Fixation Reagents
§ Proteolytic Enzymes
§ Organic Solvents
§ Chromogenic Substrates
§ Histological Stains
§ Diluents
§ Blocking Sera and Reagents
§ Others
o Equipment
§ Tissue Processing Systems
§ Slide Scanners
§ Slide-staining systems
§ Others
o Antibodies
§ Primary antibodies
§ Secondary antibodies
o Kits
§ IHC Kits for Human Tissue
§ IHC Kits for Animal Tissue
· By Applications
o Diagnostic
§ Infectious Diseases
§ Neurological Diseases
§ Autoimmune Diseases
§ Cancer
§ Nephrological Diseases
§ Others
o Research
§ Drug Development and Testing
§ Others
o Forensic
· By End-users
o Hospitals and Diagnostic Laboratories
o Academic and Research Institutes
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
Major participants in the global immunohistochemistry market are proactively seeking strategic alliances to propel progress and creativity. These partnerships encompass teaming up with research organizations, healthcare entities, and tech companies to augment research initiatives and broaden market influence. Collaborative ventures and alliances provide access to diverse expertise, technologies, and resources, nurturing the advancement of sophisticated immunohistochemistry solutions. Such partnerships further enable market entry, empowering companies to harness collective capabilities, innovate new uses, and introduce enhanced diagnostic instruments. The concerted effort amplifies their competitive advantage and fortifies the market's growth and evolution by delivering improved offerings. Agilent Technologies, Inc. and Akoya Biosciences, Inc. announced a collaboration in January 2023 to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to market workflow solutions for multiplex assays in the clinical research market. One end-to-end commercial workflow includes reagents, staining, imaging, and analysis created by integrating Agilent's Dako Omnis (autostaining instrument) and Akoya's PhenoImager HT (imaging platform) for multiplex chromogenic immunohistochemistry (mIHC) and immunofluorescent (mIF) assays.
Key Players Operating in Global Immunohistochemistry Market are:
· Agilent Technologies, Inc.
· Danaher Corporation
· PHC Holdings Corporation
· Bio-Rad Laboratories, Inc.
· Bio-Techne Corporation
· Merck KGaA
· Thermo Fisher Scientific, Inc.
· Abcam plc
· PerkinElmer Inc.
· Takara Bio Inc.
Markets and Data’s report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global immunohistochemistry market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Immunohistochemistry Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.Value
4.1.2.Volume
4.2. By Product
4.2.1.Reagents
4.2.1.1. Fixation Reagents
4.2.1.2. Proteolytic Enzymes
4.2.1.3. Organic Solvents
4.2.1.4. Chromogenic Substrates
4.2.1.5. Histological Stains
4.2.1.6. Diluents
4.2.1.7. Blocking Sera and Reagents
4.2.1.8. Others
4.2.2.Equipment
4.2.2.1. Tissue Processing Systems
4.2.2.2. Slide Scanners
4.2.2.3. Slide-staining systems
4.2.2.4. Others
4.2.3.Antibodies
4.2.3.1. Primary antibodies
4.2.3.2. Secondary antibodies
4.2.4.Kits
4.2.4.1. IHC Kits for Human Tissue
4.2.4.2. IHC Kits for Animal Tissue
4.3. By Applications
4.3.1.Diagnostic
4.3.1.1. Infectious Diseases
4.3.1.2. Neurological Diseases
4.3.1.3. Autoimmune Diseases
4.3.1.4. Cancer
4.3.1.5. Nephrological Diseases
4.3.1.6. Others
4.3.2.Research
4.3.2.1. Drug development and Testing
4.3.2.2. Others
4.3.3.Forensic
4.4. By End-users
4.4.1.Hospitals and Diagnostic Laboratories
4.4.2.Academic and Research Institutes
4.4.3.Others
4.5. By Region
5.4.1. North America
5.4.2. Europe
5.4.3. South America
5.4.4. Asia-Pacific
5.4.5. Middle East and Africa
4.6. By Company Market Share (%), 2023
5. Global Immunohistochemistry Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. Value
5.1.1.2. Volume
5.1.2.By Product
5.1.2.1. Reagents
5.1.2.1.1. Fixation Reagents
5.1.2.1.2. Proteolytic Enzymes
5.1.2.1.3. Organic Solvents
5.1.2.1.4. Chromogenic Substrates
5.1.2.1.5. Histological Stains
5.1.2.1.6. Diluents
5.1.2.1.7. Blocking Sera and Reagents
5.1.2.1.8. Others
5.1.2.2. Equipment
5.1.2.2.1. Tissue Processing Systems
5.1.2.2.2. Slide Scanners
5.1.2.2.3. Slide-staining systems
5.1.2.2.4. Others
5.1.2.3. Antibodies
5.1.2.3.1. Primary antibodies
5.1.2.3.2. Secondary antibodies
5.1.2.4. Kits
5.1.2.4.1. IHC Kits for Human Tissue
5.1.2.4.2. IHC Kits for Animal Tissue
5.1.3.By Applications
5.1.3.1. Diagnostic
5.1.3.1.1. Infectious Diseases
5.1.3.1.2. Neurological Diseases
5.1.3.1.3. Autoimmune Diseases
5.1.3.1.4. Cancer
5.1.3.1.5. Nephrological Diseases
5.1.3.1.6. Others
5.1.3.2. Research
5.1.3.2.1. Drug development and Testing
5.1.3.2.2. Others
5.1.3.3. Forensic
5.1.4.By End-users
5.1.4.1. Hospitals and Diagnostic Laboratories
5.1.4.2. Academic and Research Institutes
5.1.4.3. Others
5.1.5.United States*
5.1.5.1. Market Size & Forecast
5.1.5.1.1. Value
5.1.5.1.2. Volume
5.1.5.2. By Product
5.1.5.2.1. Reagents
5.1.5.2.1.1. Fixation Reagents
5.1.5.2.1.2. Proteolytic Enzymes
5.1.5.2.1.3. Organic Solvents
5.1.5.2.1.4. Chromogenic Substrates
5.1.5.2.1.5. Histological Stains
5.1.5.2.1.6. Diluents
5.1.5.2.1.7. Blocking Sera and Reagents
5.1.5.2.1.8. Others
5.1.5.2.2. Equipment
5.1.5.2.2.1. Tissue Processing Systems
5.1.5.2.2.2. Slide Scanners
5.1.5.2.2.3. Slide-staining systems
5.1.5.2.2.4. Others
5.1.5.2.3. Antibodies
5.1.5.2.3.1. Primary antibodies
5.1.5.2.3.2. Secondary antibodies
5.1.5.2.4. Kits
5.1.5.2.4.1. IHC Kits for Human Tissue
5.1.5.2.4.2. IHC Kits for Animal Tissue
5.1.5.3. By Applications
5.1.5.3.1. Diagnostic
5.1.5.3.1.1. Infectious Diseases
5.1.5.3.1.2. Neurological Diseases
5.1.5.3.1.3. Autoimmune Diseases
5.1.5.3.1.4. Cancer
5.1.5.3.1.5. Nephrological Diseases
5.1.5.3.1.6. Others
5.1.5.3.2. Research
5.1.5.3.2.1. Drug development and Testing
5.1.5.3.2.2. Others
5.1.5.3.3. Forensic
5.1.5.4. By End-users
5.1.5.4.1. Hospitals and Diagnostic Laboratories
5.1.5.4.2. Academic and Research Institutes
5.1.5.4.3. Others
5.1.6.Canada
5.1.7.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. South America
5.3.1.Brazil
5.3.2.Argentina
5.4. Asia-Pacific
5.4.1.India
5.4.2.China
5.4.3.Japan
5.4.4.Australia
5.4.5.Vietnam
5.4.6.South Korea
5.4.7.Indonesia
5.4.8.Philippines
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Product
6.2. By Applications
6.3. By End-users
6.4. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Agilent Technologies, Inc.
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. Danaher Corporation
13.3. PHC Holdings Corporation
13.4. Bio-Rad Laboratories, Inc.
13.5. Bio-Techne Corporation
13.6. Merck KGaA
13.7. Thermo Fisher Scientific, Inc.
13.8. Abcam plc
13.9. PerkinElmer Inc.
13.10. Takara Bio Inc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 3. Global Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 4. Global Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 5. Global Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 6. Global Immunohistochemistry Market Share (%), By Region, 2017-2031F
Figure 7. North America Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 9. North America Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 10. North America Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 11. North America Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 12. North America Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 13. United States Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 15. United States Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 16. United States Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 17. United States Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 18. Canada Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 20. Canada Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 21. Canada Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 22. Canada Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 23. Mexico Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 25. Mexico Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 26. Mexico Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 27. Mexico Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 28. Europe Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 30. Europe Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 31. Europe Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 32. Europe Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 33. Europe Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 34. Germany Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 36. Germany Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 37. Germany Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 38. Germany Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 39. France Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 41. France Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 42. France Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 43. France Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 44. Italy Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 46. Italy Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 47. Italy Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 48. Italy Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 49. United Kingdom Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 51. United Kingdom Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 52. United Kingdom Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 53. United Kingdom Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 54. Russia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 56. Russia Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 57. Russia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 58. Russia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 59. Netherlands Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 61. Netherlands Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 62. Netherlands Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 63. Netherlands Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 64. Spain Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 66. Spain Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 67. Spain Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 68. Spain Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 69. Turkey Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 71. Turkey Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 72. Turkey Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 73. Turkey Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 74. Poland Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 76. Poland Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 77. Poland Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 78. Poland Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 79. South America Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 81. South America Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 82. South America Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 83. South America Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 84. South America Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 87. Brazil Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 88. Brazil Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 89. Brazil Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 90. Argentina Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 92. Argentina Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 93. Argentina Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 94. Argentina Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 95. Asia-Pacific Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 97. Asia-Pacific Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 98. Asia-Pacific Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 99. Asia-Pacific Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 100. Asia-Pacific Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 101. India Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 103. India Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 104. India Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 105. India Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 106. China Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 108. China Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 109. China Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 110. China Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 111. Japan Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 113. Japan Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 114. Japan Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 115. Japan Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 116. Australia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 118. Australia Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 119. Australia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 120. Australia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 121. Vietnam Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 123. Vietnam Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 124. Vietnam Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 125. Vietnam Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 126. South Korea Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 128. South Korea Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 129. South Korea Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 130. South Korea Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 131. Indonesia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 133. Indonesia Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 134. Indonesia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 135. Indonesia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 136. Philippines Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 138. Philippines Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 139. Philippines Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 140. Philippines Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 141. Middle East & Africa Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 143. Middle East & Africa Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 144. Middle East & Africa Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 145. Middle East & Africa Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 146. Middle East & Africa Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 149. Saudi Arabia Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 150. Saudi Arabia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 151. Saudi Arabia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 152. UAE Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 154. UAE Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 155. UAE Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 156. UAE Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 157. South Africa Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 159. South Africa Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 160. South Africa Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 161. South Africa Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What are the regions covered in the final report for global immunohistochemistry market?
What are the major factors influencing the growth of global immunohistochemistry market?
Who are the key players operating in the global immunohistochemistry market?
What is the market size and growth rate of global immunohistochemistry market?
See Related Reports
Global Coffee Market Assessment, Opportunities and Forecast, 2017-2031F
Global coffee market is expected to experience growth due to consumers’ increasing preference for organic and premium coffee that offers freshness, superior quality of beans and roasts, and unique flavor profile. Additionally, the product innovation,....Read More
Published on
July 2024
4,500
Global Home Theater System Market Assessment, Opportunities and Forecast, 2017-2031F
Global home theater system market is expected to experience growth due to technological advancements, increasing disposable incomes, rising demand for high-definition content, integration with smart home systems, and the surge in streaming services p....Read More
Published on
July 2024
4,500
Global Baby Food Market Assessment, Opportunities and Forecast, 2017-2031F
Global baby food market is expected to experience growth due to factors such as consumers’ increasing awareness of the nutrients which are essential for babies development and introduction of wide variety of baby foods in the market from milk powders....Read More
Published on
July 2024
4,500
Global Isoflavones Market Assessment, Opportunities and Forecast, 2017-2031F
Global isoflavones market is expected to experience growth due to increasing consumer health awareness, rising demand for functional foods and nutraceuticals, advancements in extraction technologies, and expanding applications in cosmetics, pharmaceu....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
